Peter Vanderslice

USPTO Granted Patents = 12 (Patent Applications = 2)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 95(Granted Patents)

Company Filing History:

4 out of 34

Texas Heart Institute

Texas Biotechnology Corporation

patents

4. 1 out of 11

Texas Children's Hospital

patents

5. 1 out of 1

7 Hills Pharma Inc. and Texas Heart Institute

patent

6. 1 out of 1

7 Hills Interests LLC

patent

where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12201686 - Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound (2025-01-21),

2. 11312685 - Targeting nanoparticles (2022-04-26),

3. 11311619 - Integrin activator vaccine compositions (2022-04-26),

4. 10716849 - Methods of administering novel integrin activator vaccine compositions (2020-07-21),

5. 10709781 - Integrin activator checkpoint inhibitor compositions (2020-07-14),

6. 10709780 - Integrin activator vaccine compositions (2020-07-14),

7. 10342866 - Compositions and methods for immunotherapies comprising small molecule integrin receptor-ligand agonist adjuvants (2019-07-09),

8. 10287264 - Agonists that enhance binding of integrin-expressing cells to integrin receptors (2019-05-14),

9. 9512109 - Agonists that enhance binding of integrin-expressing cells to integrin receptors (2016-12-06),

10. 6713604 - Process to inhibit binding of the integrin &agr;4&bgr;1 , to VCAM-1 fibronectin and cyclic peptides thereof (2004-03-30),

11. 6087330 - Process to inhibit binding of the integrin .alpha..sub.4 .beta..sub.1 to (2000-07-11),

12. 5510332 - Process to inhibit binding of the integrin .alpha..sub.4 62 .sub.1 to (1996-04-23),

Title: The Innovative Contributions of Peter Vanderslice

Introduction

Peter Vanderslice is a prominent inventor based in Houston, Texas, recognized for his significant contributions to the field of pharmaceuticals and immunotherapy. With a remarkable portfolio of 12 patents, he has demonstrated a commitment to advancing medical science and enhancing therapeutic options for patients.

Latest Patents

Among his latest inventions is a patent that focuses on pharmaceutical compositions, which include therapeutic antibodies and checkpoint inhibitors in combination with an integrin activating compound. This innovative approach aims to enhance the anti-tumor activity of various therapeutic antibodies and immune checkpoint inhibitors. Another noteworthy patent is for integrin activator vaccine compositions, which include antigens alongside integrin agonists or activating compounds to boost the immune response in patients.

Career Highlights

Peter Vanderslice has made substantial contributions to the research and development of medical therapies during his career. He has worked with esteemed organizations such as the Texas Heart Institute and 7 Hills Pharma LLC, where his expertise in pharmacology has been invaluable in creating groundbreaking medical solutions.

Collaborations

Throughout his career, Peter has collaborated with several notable professionals, including Darren G. Woodside and Upendra K. Marathi. These partnerships have played a crucial role in enhancing the effectiveness and applicability of his inventions.

Conclusion

In summary, Peter Vanderslice continues to be a driving force in the field of innovation, particularly in pharmaceuticals and immunotherapy. His ongoing efforts in creating effective medical compositions and vaccines exemplify his dedication to improving patient outcomes through science and technology. With a solid track record of patents and collaborations, he remains a key figure in advancing medical treatments.

This text is generated by artificial intelligence and may not be accurate.